Charles Allen is a member of the board of 60 Degrees Pharmaceuticals, Inc. (60P) and has served as CEO of BTCS Inc. since February 5, 2014 and as Chairman of BTCS since September 11, 2014. He is responsible for BTCS' overall corporate strategy and direction. He also serves as a director of Innovation1 Biotech Inc. since December 5, 2022. He has extensive experience in business strategy, investment banking and capital markets transactions, such as financings, initial public offerings, and mergers and acquisitions. He has served as a managing director at various boutique investment banks and has worked domestically and internationally on projects in technology, media, natural resources, logistics, medical services, and financial services. He holds a Bachelor of Science in Mechanical Engineering from Lehigh University and a Master of Business Administration from the Mason School of Business at the College of William & Mary.